Janus Henderson Contrarian Fund EBIT

As of the most recent data (December 2023), JCNIX shows a EBIT of $480M. That compares with $530M in the prior-year period — down 8.0% year over year. That is above the sector sector average of $-25M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JCNIX's EBIT is now $480M (was $530M) — a 8.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Janus Henderson Contrarian Fund is outperforming or lagging.

The its sector sector average EBIT is about $-25M. Janus Henderson Contrarian Fund is at $480M, which is higher that average. That is roughly 2008.9% above the sector mean. Use the comparison chart on this page to see how JCNIX stacks up against individual peers as well.

Tracking JCNIX's ebit over time shows whether Janus Henderson Contrarian Fund is scaling, shrinking, or reshaping that part of the business. The current reading is $480M That compares with $530M in the prior-year period — down 8.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Janus Henderson Contrarian Fund's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $480M) with ownership activity and broader fundamentals.